Home/Filings/4/0001179110-19-008009
4//SEC Filing

Toselli Richard M. 4

Accession 0001179110-19-008009

CIK 0001292519other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:06 PM ET

Size

6.0 KB

Accession

0001179110-19-008009

Insider Transaction Report

Form 4
Period: 2019-06-19
Toselli Richard M.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2019-06-19$0.75/sh72$5410,543 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    5,228
Footnotes (2)
  • [F1]Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligationsapplicable to the vesting of 250 stock-settled RSUs.
  • [F2]Between January 1, 2018 and June 20, 2019, the reporting person acquired 5,228 shares of NVIV common stock under the NVIV 401(k) plan. The information in this report is based on a plan statement dated as of June 20, 2019.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeother

Related Parties

1
  • filerCIK 0001710549

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:06 PM ET
Size
6.0 KB